Jon A. Rowley
Affiliations: | 2001 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Google:
"Jon Rowley"Mean distance: 9.01 | S | N | B | C | P |
Parents
Sign in to add mentor| David J. Mooney | grad student | 2001 | University of Michigan | |
| (Controlling myoblast phenotype with RGD -modified alginate matrices.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Adlerz K, Patel D, Rowley J, et al. (2020) Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles. Stem Cell Research. 48: 101978 |
| Lembong J, Kirian R, Takacs JD, et al. (2020) Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel System. Bioengineering (Basel, Switzerland). 7 |
| Olsen TR, Rowley JA. (2018) Corporate profile: RoosterBio, Inc. Regenerative Medicine |
| Olsen TR, Ng KS, Lock LT, et al. (2018) Peak MSC-Are We There Yet? Frontiers in Medicine. 5: 178 |
| Yuan X, Tsai AC, Farrance I, et al. (2018) Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor. Biochemical Engineering Journal. 131: 39-46 |
| Splan D, Lock L, Rowley J, et al. (2017) Rapid and robust large-scale expansion of high quality human mesenchymal stem cells for use in regenerative medicine applications Cytotherapy. 19: S146 |
| Campbell A, Brieva T, Raviv L, et al. (2015) Concise Review: Process Development Considerations for Cell Therapy. Stem Cells Translational Medicine. 4: 1155-63 |
| Lock LT, Farance I, Baraniak P, et al. (2015) Rapid and economic generation of consistent hmsc spheroids for macroscopic tissue biofabrication and therapeutic applications Cytotherapy. 17: S77 |
| Simaria AS, Hassan S, Varadaraju H, et al. (2014) Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnology and Bioengineering. 111: 69-83 |
| Bravery CA, Carmen J, Fong T, et al. (2013) Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy. 15: 9-19 |